$0.000001
At close: Dec 1, 12:05 PM EDT
Comments
Loading...
VioQuest Pharmaceuticals Analyst Ratings and Price Targets | OTC:VOQP | Benzinga
VioQuest Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for VioQuest Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for VioQuest Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for VioQuest Pharmaceuticals (VOQP) stock?
There is no price target for VioQuest Pharmaceuticals
What is the most recent analyst rating for VioQuest Pharmaceuticals (VOQP)?
There is no analyst for VioQuest Pharmaceuticals
When was the last upgrade for VioQuest Pharmaceuticals (VOQP)?
There is no last upgrade for VioQuest Pharmaceuticals
When was the last downgrade for VioQuest Pharmaceuticals (VOQP)?
There is no last downgrade for VioQuest Pharmaceuticals.
When is the next analyst rating going to be posted or updated for VioQuest Pharmaceuticals (VOQP)?
There is no next analyst rating for VioQuest Pharmaceuticals.
Is the Analyst Rating VioQuest Pharmaceuticals (VOQP) correct?
There is no next analyst rating for VioQuest Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.
